Skip to main content
. 2023 Mar 17;31(4):220. doi: 10.1007/s00520-023-07661-2

Table 3.

Hierarchical linear model analysis conducted with the whole sample (n = 166)

Independent variables GC-RS factor HNC-RS factor SIDA factor
b (95% CI) b (95% CI) b (95% CI)
Gender -0.45 (-1.18; 0.27)ns -0.45 (-1.26; 0.37)ns -0.67 (-1.67; 0.33)ns
Age 0.0001 (-0.03; 0.03)ns -0.01 (-0.05; 0–02)ns 0.005 (-0.03; 0.04)ns
Living situation 0.24 (-0.87; 1.35)ns 0.20 (-1.04; 1.44)ns 0.58 (-0.95; 2.10)ns
Educational level 0.10 (-0.57; 0.77)ns 0.46 (-0.28; 1.21)ns 0.16 (-1.07; 0.76)ns
Employment status -0.33 (-1.08; 0.4)ns -0.28 (-1.11; 0.55)ns 0.60 (-0.42; 1.61)ns
ECOG 0.19 (-0.48; 0.87)ns 0.32 (-0.43; 1.07)ns 0.21 (-0.71; 1.13)ns
Smoker 0.51 (-0.21; 1.23)ns 0.34 (-0.46; 1.14)ns 0.48 (-0.05; 1.47)ns
Alcohol use -0.51 (-1.18; 0.16)ns -0.16 (-0.91; 0–59)ns -0.68 (-1.59; 0.24)ns
HPV -0.59 (-1.32; 0.15)ns -0.54 (-1.36; 0.28)ns -1.59 (-2.60; -0.59)**
Surgery -0.70 (-0.79; 0.65)ns -0.49 (-1.3; 0.32)ns -0.11 (-1–10; 0.89)ns
Chemotherapy 0.34 (-0.35; 1.05)ns 0.38 (-0.4; 1.16)ns 0.70 (-0.26; 1.66)ns
Time
  Linear effect 0.33 (0.27; 0.38)*** 0.54 (0.46; 0.62)*** 0.37 (0.29; 0.45)***
  Quadratic effect -0.02 (-0.02; -0.01)*** -0.03 (-0.03; -0.02)*** -0.02 (-0.02; -0.01)***
  Cubic effect 0.0002 (0.0001; 0.0002)*** 0.0003 (0.0002; 0.0003)*** 0.0002 (0.0001; 0.0002)***

GC-RS, general cancer-related symptoms; HNC-RS, head and neck cancer-related symptoms; SIDA, symptom interference with daily activities; ECOG, Eastern Cooperative Oncology Group; HPV, human papilloma virus; CI, confidence interval; ns, not significant; *p < 0.05, **p < 0.01, and ***p < 0.001 (two-tailed)